Welcome to our dedicated page for Radnet news (Ticker: RDNT), a resource for investors and traders seeking the latest updates and insights on Radnet stock.
RadNet, Inc. (NASDAQ: RDNT) generates a steady flow of news as a national provider of freestanding, fixed-site diagnostic imaging services and as the parent of DeepHealth, its AI-powered health informatics division. News about RadNet often highlights developments across its network of 407 owned and/or operated outpatient imaging centers in markets such as Arizona, California, Delaware, Florida, Maryland, New Jersey, New York and Texas, as well as updates from its Digital Health segment.
Investors and observers following RDNT news will encounter announcements on topics such as acquisitions of imaging centers, expansion into new regional markets and updates on RadNet’s operational performance. For example, the company has reported acquisitions like Radiology Regional in Southwest Florida, adding multiple imaging centers and staff to its Florida footprint. Earnings releases and financial guidance updates are also frequent news items, reflecting trends in imaging volumes, segment revenue and Adjusted EBITDA for both the Imaging Center and Digital Health segments.
RadNet’s DeepHealth division is another major source of news, with press releases covering the launch of AI-powered clinical suites, imaging informatics platforms and collaborations with partners. Recent communications have described products such as Breast Suite, Thyroid Suite, Operations Suite, Diagnostic Suite and TechLive, as well as research findings published in scientific journals and showcased at industry conferences like RSNA. News may also cover strategic collaborations, including letters of intent and partnerships with companies such as GE HealthCare to expand AI-powered imaging solutions across modalities and geographies.
Because RadNet regularly issues updates on its financial results, acquisitions, digital health initiatives and research milestones, the RDNT news page can be a useful resource for tracking how the company’s imaging center operations and DeepHealth portfolio evolve over time. Readers interested in diagnostic imaging services, AI in radiology and healthcare operations technology may find RadNet’s news particularly relevant.
RadNet (NASDAQ: RDNT) has entered a partnership with Adventist Health to launch an outpatient imaging joint venture in Simi Valley, California. This initiative will include three facilities, contributing MRI, CT, PET/CT, Ultrasound, and X-ray services. RadNet will manage Adventist Health’s Nancy Reagan Breast Center, enhancing women's health services. The joint venture targets a population of approximately 125,000 and is set to commence operations by January 2021. This collaboration aims to improve imaging capabilities and service offerings in the Simi Valley medical community.
RadNet, a leader in diagnostic imaging services, announced Mark Stolper, CFO, will present at the Sidoti & Company Fall 2020 Conference on September 23rd at 12:15 p.m. Eastern Time. The event will feature live and archived webcasts accessible through their website and the Sidoti platform. RadNet operates 340 outpatient imaging centers and employs about 8,600 staff nationwide. Their primary markets include California, Maryland, and New York, providing innovative services in diagnostic imaging and radiology information technology.
RadNet announced an amendment to its senior secured first lien credit agreement, increasing revolving commitments by $57.5 million. This brings the total revolving credit facility to $195.0 million, along with $630.4 million in first lien term loans. Both facilities mature on July 1, 2023. RadNet's CFO, Mark Stolper, emphasized that this enhancement boosts financial flexibility and supports strategic growth, with a strong cash balance of $84.5 million as of June 30, 2020. The amendment was supported by major banks including Barclays and JPMorgan Chase.
RadNet reported a challenging second quarter for 2020, with a 34.1% revenue decrease to $190.6 million compared to $289.1 million in Q2 2019. Adjusted EBITDA fell 47.6% to $22.6 million. Procedural volumes have rebounded to 90% of pre-COVID levels from a low of 28% in April. The company ended the quarter with over $84 million in cash and undrawn credit lines. A collaboration with Hologic, Inc. was announced for improving breast cancer care and advancing AI solutions. Net loss attributable was $10.6 million, a significant decline from a profit of $0.10 per share last year.
RadNet, Inc. (Nasdaq: RDNT) and Hologic, Inc. (Nasdaq: HOLX) announce a definitive collaboration to enhance artificial intelligence use in breast health. Hologic will leverage RadNet’s vast data from the largest fleet of high-resolution mammography systems to improve A.I. algorithms. This partnership aims to drive innovation in patient care and clinician confidence, with RadNet upgrading its systems to Hologic’s advanced 3DQuorum technology. The collaboration follows RadNet's acquisition of DeepHealth to bolster A.I. capabilities in cancer detection.
RadNet, Inc. (NASDAQ: RDNT), a leader in diagnostic imaging services, will host a conference call on August 10, 2020, at 7:30 a.m. PT to discuss its Q2 2020 financial results. Investors can join by calling 800-437-2398 (U.S.) or 786-204-3966 (internationally). An archived replay will be available post-call at 844-512-2921 (U.S.) or 412-317-6671 (international), using passcode 7462345. With a network of 335 outpatient imaging centers and around 8,600 employees, RadNet continues to provide innovative services across the U.S.
RadNet, a leader in diagnostic imaging services, announced that Mark Stolper, CFO, will present at the Jefferies 2020 Virtual Global Healthcare Conference on June 2, 2020, at 1:30 p.m. Eastern Time. Interested parties can access the live and archived webcasts via the provided links on RadNet's website.
RadNet operates 335 imaging centers, with core markets in California, Maryland, Delaware, New Jersey, and New York. The company employs approximately 8,600 staff, including radiologists and technicians, offering a range of imaging and technology services.
Summary not available.